×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TNGX – tango therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TNGX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/3
06:05 pm
tngx
Tango Therapeutics (NASDAQ:TNGX) was given a new $15.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) was given a new $15.00 price target on by analysts at Stifel Nicolaus.
11/26
07:15 am
tngx
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/26
07:00 am
tngx
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/21
04:24 pm
tngx
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy [Seeking Alpha]
Medium
Report
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy [Seeking Alpha]
11/18
12:20 pm
tngx
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at B. Riley from $8.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at B. Riley from $8.00 to $14.00. They now have a "buy" rating on the stock.
11/18
09:00 am
tngx
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/14
07:08 pm
tngx
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue [Yahoo! Finance]
Low
Report
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue [Yahoo! Finance]
11/14
12:00 am
tngx
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price [Yahoo! Finance]
Medium
Report
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
04:15 pm
tngx
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
Low
Report
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
11/21
08:37 am
tngx
Form 8-K Tango Therapeutics, Inc. For: Nov 18
High
Report
Form 8-K Tango Therapeutics, Inc. For: Nov 18
11/21
08:34 am
tngx
Form S-3ASR Tango Therapeutics, Inc.
High
Report
Form S-3ASR Tango Therapeutics, Inc.
11/21
08:32 am
tngx
Form S-3 Tango Therapeutics, Inc.
High
Report
Form S-3 Tango Therapeutics, Inc.
11/14
04:30 pm
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Low
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
11/14
04:18 pm
tngx
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
Low
Report
Form SCHEDULE 13D/A Tango Therapeutics, Inc. Filed by: Third Rock Ventures IV, L.P.
11/13
09:00 am
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
Low
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.
11/12
12:18 pm
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Medium
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Farallon Capital Partners, L.P.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: